Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism. [PDF]
Röshammar D +14 more
europepmc +1 more source
Comparison of the efficacy of rivaroxaban and dabigatran etexilate in preventing venous thrombosis after arthroplasty: A protocol of randomized controlled trial. [PDF]
Song R, Qu R, Wang Y, Zhou D, Zhang A.
europepmc +1 more source
Deprivation and inequalities lead to worse outcomes with dabigatran etexilate [PDF]
B. Simpson +3 more
openalex +1 more source
Nutrition and prevention of venous thromboembolism [PDF]
Prophylaxis of venous thromboembolism is a major health problem in everyday clinical practice. The therapeutic anticoagulants available to clinicians for prophylaxis of VTE is mainly composed by parenteral anticoagulants and oral vitamin K antagonists ...
Mattioli, AV, Pennella, S
core
P4600Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry [PDF]
G Y H Lip +11 more
openalex +1 more source
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate [PDF]
Melissa D. Lambourne +5 more
openalex +1 more source
Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate. [PDF]
van Gorp RH +14 more
europepmc +1 more source
Presente y futuro del tratamiento anticoagulante oral [PDF]
The alternative new oral anticoagulants open a new era in antithrombotic treatment. For more than half a century, vitamin K antagonists have defined oral anticoagulant therapy for the long-term management of thrombotic disorders.
García Frade, Luis Javier
core +1 more source
216-71: Reduction of recurrence of atrial fibrillation after electrical cardioversion by Dabigatran-etexilate [PDF]
Christian Obst +3 more
openalex +1 more source

